These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 21309068

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP.
    Stankovic-Valentin N, Verger A, Deltour-Balerdi S, Quinlan KG, Crossley M, Leprince D.
    FEBS J; 2006 Jul; 273(13):2879-90. PubMed ID: 16762039
    [Abstract] [Full Text] [Related]

  • 5. Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1.
    Deltour S, Pinte S, Guérardel C, Leprince D.
    Biochem Biophys Res Commun; 2001 Sep 21; 287(2):427-34. PubMed ID: 11554746
    [Abstract] [Full Text] [Related]

  • 6. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
    Stöcklein H, Smardova J, Macak J, Katzenberger T, Höller S, Wessendorf S, Hutter G, Dreyling M, Haralambieva E, Mäder U, Müller-Hermelink HK, Rosenwald A, Ott G, Kalla J.
    Oncogene; 2008 Apr 17; 27(18):2613-25. PubMed ID: 17982487
    [Abstract] [Full Text] [Related]

  • 7. Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1.
    Pinte S, Guérardel C, Deltour-Balerdi S, Godwin AK, Leprince D.
    Oncogene; 2004 May 13; 23(22):4023-31. PubMed ID: 15007385
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
    Jenal M, Trinh E, Britschgi C, Britschgi A, Roh V, Vorburger SA, Tobler A, Leprince D, Fey MF, Helin K, Tschan MP.
    Mol Cancer Res; 2009 Jun 13; 7(6):916-22. PubMed ID: 19491197
    [Abstract] [Full Text] [Related]

  • 11. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R, Maurer J, Jacob A, Schorle H.
    Genesis; 2004 Mar 13; 38(3):145-50. PubMed ID: 15048812
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Generation of Pax2-Cre mice by modification of a Pax2 bacterial artificial chromosome.
    Ohyama T, Groves AK.
    Genesis; 2004 Apr 13; 38(4):195-9. PubMed ID: 15083520
    [Abstract] [Full Text] [Related]

  • 15. Generation of mice with a conditional null allele for Tbx2.
    Wakker V, Brons JF, Aanhaanen WT, van Roon MA, Moorman AF, Christoffels VM.
    Genesis; 2010 Mar 13; 48(3):195-9. PubMed ID: 20095052
    [Abstract] [Full Text] [Related]

  • 16. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice.
    Xin HB, Deng KY, Rishniw M, Ji G, Kotlikoff MI.
    Physiol Genomics; 2002 Sep 03; 10(3):211-5. PubMed ID: 12209023
    [Abstract] [Full Text] [Related]

  • 17. Generation of an Frs2alpha conditional null allele.
    Lin Y, Zhang J, Zhang Y, Wang F.
    Genesis; 2007 Sep 03; 45(9):554-9. PubMed ID: 17868091
    [Abstract] [Full Text] [Related]

  • 18. Generation and functional characterization of mice with a conditional BMP7 allele.
    Zouvelou V, Passa O, Segklia K, Tsalavos S, Valenzuela DM, Economides AN, Graf D.
    Int J Dev Biol; 2009 Sep 03; 53(4):597-603. PubMed ID: 19247966
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.